COVID-19 and assisted reproductive technology services: repercussions for patients and proposal for individualized clinical management
-
Published:2020-05-13
Issue:1
Volume:18
Page:
-
ISSN:1477-7827
-
Container-title:Reproductive Biology and Endocrinology
-
language:en
-
Short-container-title:Reprod Biol Endocrinol
Author:
Alviggi CarloORCID, , Esteves Sandro C.ORCID, Orvieto Raoul, Conforti Alessandro, La Marca Antonio, Fischer Robert, Andersen Claus Y., Bühler Klaus, Sunkara Sesh K., Polyzos Nikolaos P., Strina Ida, Carbone Luigi, Bento Fabiola C., Galliano Daniela, Yarali Hakan, Vuong Lan N., Grynberg Michael, Drakopoulos Panagiotis, Xavier Pedro, Llacer Joaquin, Neuspiller Fernando, Horton Marcos, Roque Matheus, Papanikolaou Evangelos, Banker Manish, Dahan Michael H., Foong Shu, Tournaye Herman, Blockeel Christophe, Vaiarelli Alberto, Humaidan Peter, Ubaldi Filippo M.
Abstract
AbstractThe prolonged lockdown of health services providing high-complexity fertility treatments –as currently recommended by many reproductive medicine entities– is detrimental for society as a whole, and infertility patients in particular. Globally, approximately 0.3% of all infants born every year are conceived using assisted reproductive technology (ART) treatments. By contrast, the total number of COVID-19 deaths reported so far represents approximately 1.0% of the total deaths expected to occur worldwide over the first three months of the current year. It seems, therefore, that the number of infants expected to be conceived and born –but who will not be so due to the lockdown of infertility services– might be as significant as the total number of deaths attributed to the COVID-19 pandemic. We herein propose remedies that include a prognostic-stratification of more vulnerable infertility cases in order to plan a progressive restart of worldwide fertility treatments. At a time when preventing complications and limiting burdens for national health systems represent relevant issues, our viewpoint might help competent authorities and health care providers to identify patients who should be prioritized for the continuation of fertility care in a safe environment.
Publisher
Springer Science and Business Media LLC
Subject
Developmental Biology,Endocrinology,Reproductive Medicine,Obstetrics and Gynaecology
Reference32 articles.
1. ASRM. American Society For Reproductive Medicine (Asrm) Patient Management And Clinical Recommendationsduring The Coronavirus (Covid-19) Pandemic Available from: https://www.asrm.org/news-and-publications/covid-19/statements/patient-management-and-clinical-recommendations-during-the-coronavirus-covid-19-pandemic/. 2020. 2. ESHRE. Coronavirus Covid-19: ESHRE statement on pregnancy and conception. 2020. 3. COVID-19. Coronavirus Pandemic. Available from: https://www.worldometers.info/coronavirus/. 2020. 4. Esteves SC, Alviggi C, Humaidan P, Fischer R, Andersen CY, Conforti A, et al. The POSEIDON criteria and its measure of success through the eyes of clinicians and embryologists. Front Endocrinol (Lausanne). 2019;10:814. 5. Adamson GD, de Mouzon J, Chambers GM, Zegers-Hochschild F, Mansour R, Ishihara O, et al. International Committee for Monitoring Assisted Reproductive Technology: world report on assisted reproductive technology, 2011. Fertil Steril. 2018;110:1067–80.
Cited by
79 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|